Jennifer FranklinExecutive Director, CMC Regulatory Affairs at Ionis PharmaceuticalsSpeaker
Profile
Jenny has worked for Ionis Pharmaceuticals, Inc. for 18 years. For the past eight, she has been responsible for CMC Regulatory Affairs for Ionis programs from early development through marketing authorization and commercial lifecycle management. Prior to that, she was responsible for Quality Assurance oversight of oligonucleotide drug substance manufacturing and testing activities, and associated functions. Before joining Ionis, Jenny worked in Quality Control for Gala Biotech (now Catalent BioPharma). She earned her B.S in Biology and French from the University of Wisconsin.
Agenda Sessions
Practical Application of Platform Approaches for Oligonucleotides
, 10:45View Session